TG Therapeutics (TGTX) had the highest return between March 3, 2017 and March 10, 2017 by a US stock, returning 103.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
TG Therapeutics (TGTX) | 3/3/2017 - 3/10/2017 | 103.57% |
Lixte Biotechnology (LIXT) | 3/3/2017 - 3/10/2017 | 102.02% |
Sobr Safe (SOBR) | 3/3/2017 - 3/10/2017 | 100% |
Aurinia Pharmaceuticals (AUPH) | 3/3/2017 - 3/10/2017 | 80.85% |
Reliance Global (RELI) | 3/3/2017 - 3/10/2017 | 74.95% |
Astria Therapeutics (ATXS) | 3/3/2017 - 3/10/2017 | 74.36% |
LifeMD (LFMD) | 3/3/2017 - 3/10/2017 | 65.63% |
Opus Genetics (IRD) | 3/3/2017 - 3/10/2017 | 62.67% |
Scienture (SCNX) | 3/3/2017 - 3/10/2017 | 58.7% |
Avalo Therapeutics (AVTX) | 3/3/2017 - 3/10/2017 | 57.89% |
Datasea (DTSS) | 3/3/2017 - 3/10/2017 | 51.25% |
Quipt Home Medical (QIPT) | 3/3/2017 - 3/10/2017 | 46.43% |
Houston American Energy (HUSA) | 3/3/2017 - 3/10/2017 | 39.13% |
Nutex Health (NUTX) | 3/3/2017 - 3/10/2017 | 36.84% |
Navios Maritime Partners LP Unit (NMM) | 3/3/2017 - 3/10/2017 | 34.05% |
Palvella Therapeutics (PVLA) | 3/3/2017 - 3/10/2017 | 32.56% |
iBio, Inc Common Stock (IBIO) | 3/3/2017 - 3/10/2017 | 31.65% |
Clearpoint Neuro (CLPT) | 3/3/2017 - 3/10/2017 | 31.43% |
Castellum (CTM) | 3/3/2017 - 3/10/2017 | 30% |
XOMA (XOMA) | 3/3/2017 - 3/10/2017 | 29.83% |
QuickLogic (QUIK) | 3/3/2017 - 3/10/2017 | 29.38% |
Soligenix (SNGX) | 3/3/2017 - 3/10/2017 | 29.21% |
Corvus Pharmaceuticals (CRVS) | 3/3/2017 - 3/10/2017 | 26.98% |
SurgePays (SURG) | 3/3/2017 - 3/10/2017 | 25.93% |
AlphaTON Capital (ATON) | 3/3/2017 - 3/10/2017 | 25.81% |
